XML 42 R29.htm IDEA: XBRL DOCUMENT
v3.20.4

Stock-Based Compensation | 12 Months Ended
--- | ---
Oct. 03, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract] |
Stock-Based Compensation | STOCK-BASED COMPENSATION We issue shares under our stock-based compensation plans by issuing Class A stock from treasury. The total number of shares available for future grant under the Tyson Foods, Inc. 2000 Stock Incentive Plan (“Incentive Plan”) was 9,979,081 at October 3, 2020. Stock Options Shareholders approved the Incentive Plan in January 2001. The Incentive Plan is administered by the Compensation and Leadership Development Committee of the Board of Directors (“Compensation Committee”). The Incentive Plan includes provisions for granting incentive stock options for shares of Class A stock at a price not less than the fair value at the date of grant. Nonqualified stock options may be granted at a price equal to or more than the fair value of Class A stock on the date the option is granted. Stock options under the Incentive Plan generally become exercisable ratably over three years from the date of grant and must be exercised within 10 years from the date of grant. Our policy is to recognize compensation expense on a straight-line basis over the requisite service period for the entire award. Forfeitures are recognized as they occur.
| Shares Under Option |  | Weighted Average Exercise Price Per Share |  | Weighted Average Remaining Contractual Life (in Years) |  | Aggregate Intrinsic Value (in millions)
Outstanding, September 28, 2019 | 5,362,672 |  |  | $ | 54.03 |  |  |  |  |
Exercised | (661,549) |  |  | 48.21 |  |  |  |  |
Forfeited or expired | (265,237) |  |  | 76.06 |  |  |  |  |
Granted | 1,515,587 |  |  | 90.04 |  |  |  |  |
Outstanding, October 3, 2020 | 5,951,473 |  |  | $ | 62.86 |  |  | 6.8 |  | $ | 37 |
Exercisable, October 3, 2020 | 3,231,765 |  |  | $ | 50.96 |  |  | 5.4 |  | $ | 37 |
The weighted average grant-date fair value of options granted in fiscal 2020, 2019 and 2018 was $16.77, $11.35 and $18.31, respectively. The fair value of each option grant is established on the date of grant using a binomial lattice method. We use historical volatility for a period of time comparable to the expected life of the option to determine volatility assumptions. Expected life is calculated based on the contractual term of each grant and takes into account the historical exercise and termination behavior of participants. Risk-free interest rates are based on the five-year Treasury bond rate. Assumptions used in the fair value calculation are as of the grant dates and are outlined in the following table.
| 2020 |  | 2019 |  | 2018
Expected life (in years) | 4.3 |  | 4.3 |  | 5.9
Risk-free interest rate | 1.6 | % |  | 2.8 | % |  | 2.1 | %
Expected volatility | 25.7 | % |  | 25.4 | % |  | 23.5 | %
Expected dividend yield | 2.0 | % |  | 2.5 | % |  | 1.5 | %
We recognized stock-based compensation expense related to stock options, net of income taxes, of $16 million, $16 million and $13 million for fiscal 2020, 2019 and 2018, respectively. The related tax benefit for fiscal 2020, 2019 and 2018 was $4 million, $3 million and $6 million, respectively. We had 1.3 million, 1.2 million and 2.2 million options vest in fiscal 2020, 2019 and 2018, respectively, with a grant date fair value of $17 million, $18 million and $27 million, respectively. In fiscal 2020, 2019 and 2018, we received cash of $30 million, $99 million and $102 million, respectively, for the exercise of stock options. Shares are issued from treasury for stock option exercises. The related tax benefit realized from stock options exercised during fiscal 2020, 2019 and 2018, was $6 million, $21 million and $30 million, respectively. The total intrinsic value of options exercised in fiscal 2020, 2019 and 2018, was $21 million, $79 million and $103 million, respectively. Cash flows resulting from tax deductions in excess of the compensation cost of those options (excess tax deductions) are classified as financing cash flows. We realized $4 million, $14 million and $20 million related to excess tax deductions during fiscal 2020, 2019 and 2018, respectively. As of October 3, 2020, we had $21 million of total unrecognized compensation cost related to stock option plans that will be recognized over a weighted average period of 1.3 years. Restricted Stock We issue restricted stock at the market value as of the date of grant, with restrictions expiring over periods through fiscal 2023. Unearned compensation is recognized over the vesting period for the particular grant using a straight-line method.
| Number of Shares |  | Weighted Average Grant- Date Fair Value Per Share |  | Weighted Average Remaining Contractual Life (in Years) |  | Aggregate Intrinsic Value (in millions)
Nonvested, September 28, 2019 | 1,662,078 |  |  | $ | 64.55 |  |  |  |  |
Granted | 628,844 |  |  | 88.96 |  |  |  |  |
Dividends | 44,704 |  |  | 74.51 |  |  |  |  |
Vested | (556,632) |  |  | 60.30 |  |  |  |  |
Forfeited | (116,585) |  |  | 74.18 |  |  |  |  |
Nonvested, October 3, 2020 | 1,662,409 |  |  | $ | 74.79 |  |  | 1.3 |  | $ | 99 |
As of October 3, 2020, we had $49 million of total unrecognized compensation cost related to restricted stock awards that will be recognized over a weighted average period of 1.8 years. We recognized stock-based compensation expense related to restricted stock, net of income taxes, of $36 million, $26 million and $22 million for fiscal 2020, 2019 and 2018, respectively. The related tax benefit for fiscal 2020, 2019 and 2018 was $9 million, $8 million and $9 million, respectively. We had 0.6 million, 0.5 million and 0.6 million restricted stock awards vest in fiscal 2020, 2019 and 2018, respectively, with a grant date fair value of $34 million, $29 million and $27 million, respectively. Performance-Based Shares We award performance-based shares of our Class A stock to certain team members. These awards are typically granted once a year. Performance-based shares vest based upon the passage of time and the achievement of performance or market performance criteria, ranging from 0% to 200%, as determined by the Compensation Committee prior to the date of the award. Vesting periods for these awards are three years. We review progress toward the attainment of the performance criteria each quarter during the vesting period. When it is probable the minimum performance criteria for an award will be achieved, we begin recognizing the expense equal to the proportionate share of the total fair value of the Class A stock price on the grant date. The total expense recognized over the duration of performance awards will equal the Class A stock price on the date of grant multiplied by the number of shares ultimately awarded based on the level of attainment of the performance criteria. For grants with market performance criteria, the fair value is determined on the grant date and is calculated using the same inputs for expected volatility, expected dividend yield, and risk-free rate as stock options, noted above, with a duration of three years. The total expense recognized over the duration of the award will equal the fair value, regardless if the market performance criteria is met. The following table summarizes the performance-based shares at the maximum award amounts based upon the respective performance share agreements. Actual shares that will vest depend on the level of attainment of the performance-based criteria.
| Number of Shares |  | Weighted Average Grant- Date Fair Value Per Share |  | Weighted Average Remaining Contractual Life (in Years) |  | Aggregate Intrinsic Value (in millions)
Nonvested, September 28, 2019 | 2,027,059 |  |  | $ | 51.03 |  |  |  |  |
Granted | 726,388 |  |  | 67.55 |  |  |  |  |
Vested | (344,870) |  |  | 46.29 |  |  |  |  |
Forfeited | (445,440) |  |  | 52.59 |  |  |  |  |
Nonvested, October 3, 2020 | 1,963,137 |  |  | $ | 57.62 |  |  | 1.2 |  | $ | 116 |
We recognized stock-based compensation expense related to performance shares, net of income taxes, of $18 million, $16 million and $12 million for fiscal 2020, 2019 and 2018, respectively. The related tax benefit for fiscal 2020, 2019 and 2018 was $4 million, $4 million and $5 million, respectively. As of October 3, 2020, we had $33 million of total unrecognized compensation based upon our progress toward the attainment of criteria related to performance-based share awards that will be recognized over a weighted average period of 1.9 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration